News | Radiation Therapy | January 02, 2018

Water phantom system enables fast and seamless beam scanning

Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine

January 2, 2018 — IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian Halcyon radiation therapy system in Europe to go clinical, at the hospital UZ Leuven in Belgium, using IBA Dosimetry’s Blue Phantom water phantom system.

Prof. Tom Depuydt, head of physics at UZ Leuven, Belgium, said: “We are very happy to announce that we were able to deliver the first treatment fraction with the Varian Halcyon system on Oct. 2nd, within just 14 days of the machine’s installation. This was made possible by the fruitful collaboration of our physics team and IBA Dosimetry, and use of the Blue Phantom system to ensure fast and reliable acceptance of our new machine.”

The Blue Phantom system enables fast and seamless beam scanning workflows that are ideal for verification and annual quality assurance (QA) of the Varian Halcyon. Next to the compact design, the phantom’s conveniently accessible micro-leveling frame enables fast and precise system setup.

For more information: www.iba-worldwide.com

Related Content

News | Quality Assurance (QA)

October 11, 2021 — To maintain safety in radiation therapy (RT), every machine performance and patient delivery ...

Time October 11, 2021
arrow
News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
Feature | Radiation Therapy | By Dave Fornell

To maintain safety in radiation therapy (RT), every machine performance and patient delivery measurement must be as ...

Time October 05, 2021
arrow
Feature | Radiation Therapy

September 28, 2021 — New research from Washington University School of Medicine in St. Louis suggests that radiation ...

Time September 28, 2021
arrow
News | Radiation Oncology

September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 ...

Time September 28, 2021
arrow
News | Prostate Cancer

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
News | Radiation Therapy

September 24, 2021 — The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s ...

Time September 24, 2021
arrow
News | Lung Imaging

September 23, 2021 — The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center ...

Time September 23, 2021
arrow
News | Radiation Oncology

September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatment ...

Time September 21, 2021
arrow
News | Radiation Oncology

September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, means ...

Time September 20, 2021
arrow
Subscribe Now